Nanomedicine has been considered a promising tool for biomedical research and clinical
practice in the 21st century because of the great impact nanomaterials could have on human …

Nanomedicines, since the approval of the first one in the 1950s, have been accompanied by
expectations of higher efficiency and efficacy, compared to less complex drugs. The …

Nanomedicines are complex drugs where components that have typically been regarded as
excipients may now be considered part of the active ingredient. The distinction between the …

Despite their clinical success in drug delivery applications, the potential of theranostic
nanomedicines is hampered by mechanistic uncertainty and a lack of science-informed …

Over the past two decades, nanomedicine has grown steadily, however, without inducing a
palpable shift in the diagnosis and treatment of diseases so far. While this may simply be a …

Nanomedicine plays an essential role in developing new therapies through novel drug
delivery systems, diagnostic and imaging systems, vaccine development, antibacterial tools …

The advent of the twenty-first century marked a paradigm shift in the healthcare sector with
coming of automated, sensitive, targeted medicines and technologies having diagnostic …

To guide developers of innovative and generic drug products that contain nanomaterials, the
US Food and Drug Administration issued the draft guidance for industry titled:“Drug …

Intravenous iron-carbohydrate nanomedicines are widely used to treat iron deficiency and
iron deficiency anemia across a wide breadth of patient populations. These colloidal …

Scientific and technological breakthroughs in the field of Nanotechnology have been a
driving force throughout the development and approval of Non-Biological Complex Drugs …